Spago Nanomedical AB (OSTO:SPAGO) Ending Cash Position : kr47.70 Mil (As of Jun. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB Ending Cash Position?

Spago Nanomedical AB's Ending Cash Position for the quarter that ended in Jun. 2024 was kr47.70 Mil.

Spago Nanomedical AB's quarterly Ending Cash Position declined from Dec. 2023 (kr45.22 Mil) to Mar. 2024 (kr32.25 Mil) but then increased from Mar. 2024 (kr32.25 Mil) to Jun. 2024 (kr47.70 Mil).

Spago Nanomedical AB's annual Ending Cash Position increased from Dec. 2021 (kr52.46 Mil) to Dec. 2022 (kr62.10 Mil) but then declined from Dec. 2022 (kr62.10 Mil) to Dec. 2023 (kr45.22 Mil).

Spago Nanomedical AB Ending Cash Position Historical Data

The historical data trend for Spago Nanomedical AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Ending Cash Position Chart

Spago Nanomedical AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

12.15

28.45

52.46

62.10

45.22

Spago Nanomedical AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial															31.39	25.97	45.22	32.25	47.70

Spago Nanomedical AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Spago Nanomedical AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	62.102	+	-16.885
	=	45.22

Spago Nanomedical AB's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	32.25	+	15.45
	=	47.70

Spago Nanomedical AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Spago Nanomedical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 22, Lund, SWE, SE-223 63

Website

https://www.spagonanomedical.se

Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB Headlines

No Headlines